Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats

  • Authors:
    • Yongxia Cheng
    • Sufen Guo
    • Guibo Liu
    • Yukuan Feng
    • Bin Yan
    • Jianbo Yu
    • Kejian Feng
    • Zhiqiang Li
  • View Affiliations

  • Published online on: July 31, 2012     https://doi.org/10.3892/ijmm.2012.1083
  • Pages: 870-876
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Diabetic cardiomyopathy (DCM) is a progressive disease of the heart muscle and the third most common cause of heart failure. In the present study, we evaluated the effects of bone marrow‑derived endothelial progenitor cell (EPC) transplantation on the development of DCM in a streptozotocin (STZ)-induced diabetic rat model. Ex vivo generated, characterized and cultivated rat EPCs were identified by flow cytometry of their surface markers. EPCs were transplanted intravenously into rats through the tail vein 6 weeks after they were challenged with STZ and the rats were sacrificed 4 weeks later. Before sacrifice, left ventricular (LV) catheterization was performed to evaluate the cardiac function. Myocardium sections were stained with Masson's trichrome staining to investigate myocardial collagen contents. Fibrosis-, apoptosis- and oxidative stress-related gene expressions were analyzed by western blot analysis. Transplantation of EPCs alleviated the impaired cardiac function associated with diabetes and decreased the collagen volume in diabetic myocardium resulting in improved cardiac function. Furthermore, EPC transplantation decreased the expression of type I collagen, Bax, caspase-3 and p67phox, while increasing the expression of Bcl-2 and manganese superoxide dismutase (MnSOD). Taken together, our results suggest that transplantation of EPCs improved cardiac function in the rat DCM model, likely through inhibition of cardiomyocyte apoptosis and attenuating myocardial fibrosis.
View Figures
View References

Related Articles

Journal Cover

October 2012
Volume 30 Issue 4

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cheng Y, Guo S, Liu G, Feng Y, Yan B, Yu J, Feng K and Li Z: Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats. Int J Mol Med 30: 870-876, 2012
APA
Cheng, Y., Guo, S., Liu, G., Feng, Y., Yan, B., Yu, J. ... Li, Z. (2012). Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats. International Journal of Molecular Medicine, 30, 870-876. https://doi.org/10.3892/ijmm.2012.1083
MLA
Cheng, Y., Guo, S., Liu, G., Feng, Y., Yan, B., Yu, J., Feng, K., Li, Z."Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats". International Journal of Molecular Medicine 30.4 (2012): 870-876.
Chicago
Cheng, Y., Guo, S., Liu, G., Feng, Y., Yan, B., Yu, J., Feng, K., Li, Z."Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats". International Journal of Molecular Medicine 30, no. 4 (2012): 870-876. https://doi.org/10.3892/ijmm.2012.1083